Jetema Signs KRW 30.15 Billion Exclusive Toxin Supply Contract

• Jetema signed a KRW 30.15 billion exclusive toxin supply contract with a domestic pharmaceutical distributor on Oct. 14, 2026.
• The contract represents 39.66% of recent revenue and runs through Oct. 14, 2031.
• Payment requires 100% advance payment by telegraphic transfer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jetema Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261015900270), on October 15, 2026, and is solely responsible for the information contained therein.